Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Ductal pancreatic cancer in humans and mice.

Tuveson DA, Hingorani SR.

Cold Spring Harb Symp Quant Biol. 2005;70:65-72. Review.

PMID:
16869739
2.

[Precursors to pancreatic cancer].

Søreide K, Immervoll H, Molven A.

Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8. Review. Norwegian.

3.

Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?

Haugk B.

Histopathology. 2010 Oct;57(4):503-14. doi: 10.1111/j.1365-2559.2010.03610.x. Epub 2010 Sep 28. Review.

PMID:
20875068
4.

Pancreatic cancer: a plea for good and comprehensive morphological studies.

Algül H, Schmid RM.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):713-5. doi: 10.1097/MEG.0b013e3282f9460e. Review.

PMID:
18617774
5.

Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Mahadevan D, Von Hoff DD.

Mol Cancer Ther. 2007 Apr;6(4):1186-97. Epub 2007 Apr 3. Review.

6.

Genetics and biology of pancreatic ductal adenocarcinoma.

Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.

Genes Dev. 2006 May 15;20(10):1218-49. Review.

7.

Stromal biology and therapy in pancreatic cancer.

Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, Tuveson DA.

Gut. 2011 Jun;60(6):861-8. doi: 10.1136/gut.2010.226092. Epub 2010 Oct 21. Review.

PMID:
20966025
8.

Molecular pathogenesis of pancreatic cancer.

Maitra A, Kern SE, Hruban RH.

Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):211-26. Review.

PMID:
16549325
9.

MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?

Mardin WA, Mees ST.

Ann Surg Oncol. 2009 Nov;16(11):3183-9. doi: 10.1245/s10434-009-0623-1. Epub 2009 Jul 28. Review.

PMID:
19636633
10.

Current topics on precursors to pancreatic cancer.

Takaori K, Hruban RH, Maitra A, Tanigawa N.

Adv Med Sci. 2006;51:23-30. Review.

PMID:
17357272
11.

Current understanding of precursors to pancreatic cancer.

Takaori K.

J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. Epub 2007 May 29. Review.

PMID:
17520195
12.

Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.

Wescott MP, Rustgi AK.

Cancer Prev Res (Phila). 2008 Dec;1(7):503-6. doi: 10.1158/1940-6207.CAPR-08-0195. Review.

13.

Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.

Hidalgo M, Von Hoff DD.

Clin Cancer Res. 2012 Aug 15;18(16):4249-56. doi: 10.1158/1078-0432.CCR-12-1327. Review.

14.

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.

Mazur PK, Siveke JT.

Gut. 2012 Oct;61(10):1488-500. doi: 10.1136/gutjnl-2011-300756. Epub 2011 Aug 26. Review.

PMID:
21873467
15.

Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men.

Ottenhof NA, Milne AN, Morsink FH, Drillenburg P, Ten Kate FJ, Maitra A, Offerhaus GJ.

Arch Pathol Lab Med. 2009 Mar;133(3):375-81. doi: 10.1043/1543-2165-133.3.375. Review.

PMID:
19260743
16.

Pancreatic biomarkers: could they be the answer?

Lamarca A, Feliu J.

World J Gastroenterol. 2014 Jun 28;20(24):7819-29. doi: 10.3748/wjg.v20.i24.7819. Review.

17.

Molecular changes in pancreatic cancer.

Buchholz M, Gress TM.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1487-97. doi: 10.1586/era.09.107. Review.

PMID:
19828010
18.

Targeting reactive oxygen species in development and progression of pancreatic cancer.

Durand N, Storz P.

Expert Rev Anticancer Ther. 2017 Jan;17(1):19-31. Epub 2016 Nov 23. Review.

19.

Mutant KRAS in the initiation of pancreatic cancer.

Deramaudt T, Rustgi AK.

Biochim Biophys Acta. 2005 Nov 25;1756(2):97-101. Epub 2005 Sep 7. Review.

PMID:
16169155
20.

Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma.

Nakamoto M, Hisaoka M.

J UOEH. 2016 Mar 1;38(1):1-8. doi: 10.7888/juoeh.38.1. Review.

Supplemental Content

Support Center